Skip to main content
Clinical Trials/NL-OMON25257
NL-OMON25257
Not yet recruiting
Not Applicable

Improving medication adherence with Treatment Adherence Therapy.

Arkin Amsterdam0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Arkin Amsterdam
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Arkin Amsterdam

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis schizophrenia according to DSM\-IV criteria;
  • 2\. Current prescription of an antipsychotic medication;

Exclusion Criteria

  • 1\. Unable to follow TAT treatment due to inadequate mastery of the Dutch language, or severe cognitive impairment;
  • 2\. Severe substance abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials